摘要
糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病患者常见和严重的并发症之一,也是糖尿病患者视力损害的最主要原因,其发病率一直呈现增长的趋势。随着对DR发病机制的深入研究,通过对血糖、血压及血脂危险因子的控制,以及多种药物的应用,对DR的防治取得了可喜的进展,本文就近年来对DR的危险因子控制及药物治疗的现状做一综述。
Diabetic retinopathy ( DR ) is one of the common and serious complications of diabetes, which also the main causes of visual impairment in patients with diabetes, and its incidence has been increasing. With the in- depth study of the pathogenesis of DR, through the control of risk factors including blood glucose, blood pressure and lipid, as well as the application of a variety of drugs, the prevention and cure of DR achieved a certain effect. ln this paper, we make a review of the present status and progress in recent years on the DR control risk factors and drug intervention.
出处
《国际眼科杂志》
CAS
2014年第12期2165-2167,共3页
International Eye Science
基金
国家自然科学基金资助项目(No.81271026)
福建省自然科学基金资助项目(No.2012J01344)~~
关键词
糖尿病视网膜病变
VEGF抑制剂
糖皮质激素
蛋白酶C抑制剂
抗氧化剂
diabetic retinopathy
vascular endothelial growth factor inhibitors
corticosteroids
protein kinase C inhibitors
antioxidants